標(biāo)題: Titlebook: Viral Drug Delivery Systems; Advances in Treatmen Ranjita Shegokar,Yashwant Pathak Book 2023 The Editor(s) (if applicable) and The Author(s [打印本頁] 作者: 出租 時間: 2025-3-21 17:29
書目名稱Viral Drug Delivery Systems影響因子(影響力)
書目名稱Viral Drug Delivery Systems影響因子(影響力)學(xué)科排名
書目名稱Viral Drug Delivery Systems網(wǎng)絡(luò)公開度
書目名稱Viral Drug Delivery Systems網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Viral Drug Delivery Systems被引頻次
書目名稱Viral Drug Delivery Systems被引頻次學(xué)科排名
書目名稱Viral Drug Delivery Systems年度引用
書目名稱Viral Drug Delivery Systems年度引用學(xué)科排名
書目名稱Viral Drug Delivery Systems讀者反饋
書目名稱Viral Drug Delivery Systems讀者反饋學(xué)科排名
作者: exceed 時間: 2025-3-21 21:02 作者: 阻止 時間: 2025-3-22 02:48
978-3-031-20539-2The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl作者: fiction 時間: 2025-3-22 06:17
Ranjita Shegokar,Yashwant PathakCovers drug delivery for treatment of COVID-19, HIV, SARS, EBOLA and Influenza.Includes information on the latest clinical trials.Presents new nanoparticle delivery systems作者: Modicum 時間: 2025-3-22 09:21
geber-Dienstleister-Beziehungen. Hierzu werden zun?chst die verschiedenen Auspr?gungsformen von Betreibermodellen definitorisch eingeordnet und die Relevanz von Betreibermodellen im Facility Management aufgezeigt. Für eine erfolgreiche Umsetzung von Outsourcing-Projekten wird ein Konzept entwickelt,作者: 思想靈活 時間: 2025-3-22 15:12
Tayo Alex Adekiya,Mumuni Sumaila,Raphael Taiwo Aruleba,Yahya E. Choonaraictions as a point-in-time classification problem. This approach has limitations, particularly in capturing the evolving nature of solar activity. Recognizing the limitations of traditional flare forecasting approaches, our research aims to uncover hidden relationships and the evolutionary character作者: immunity 時間: 2025-3-22 17:24
Nidhi Mishra,Neelu Singh,Poonam ParasharAlthough the project management theory has been widely used in the construction of electric power enterprises in my country, there are still many problems. Human resource planning, as an important part of enterprise human resource management, is the extension of enterprise strategy in human resource作者: Insubordinate 時間: 2025-3-22 21:17 作者: custody 時間: 2025-3-23 02:20
Harshita Krishnatreyya,Hemanga Hazarika,Bhrigu Kumar Das,Neelutpal Gogoi,Abdul Baquee Ahmed,Kamaruz the timetable only for one direction of the bus line, which may lead to the issue of inconsistent departure numbers for the upward and downward directions on the same bus line. For bus companies, it is very important to have an equal number of departures in both directions. To ensure each bus can re作者: 調(diào)整 時間: 2025-3-23 09:32
Kavyashree Puttananjegowda,Arash Takshi,Sylvia Thomasldungsverl?ufen erzielen, untersucht das vorliegende Buch für verschiedene Bildungs- und Lebensetappen anhand multivariater Vergleiche für nichtmonet?re und monet?re Ertragsvariablen. Hierzu werden Bildungsverl?ufe von mehr als 41.000 Personen aus drei Startkohorten des Nationalen Bildungspanels auf作者: Blemish 時間: 2025-3-23 11:00
Kshama Patel,Yash Pagarani,Ranjita Shegokar,Yashwant Pathaktion approaches mainly exploit mutual exclusivity of mutated driver genes and integrate multi-omics data with gene function networks. Some of them identify driver genes based on the gene features learned by network embedding algorithms. However, these methods are limited to using the mutual exclusiv作者: ARCHE 時間: 2025-3-23 16:19 作者: bibliophile 時間: 2025-3-23 20:04
Priya Shrivastava,Suresh P. Vyas obtain high-quality retinal images. Low resolution or poor quality significantly hinders medical diagnosis, adversely affecting clinical or downstream tasks. Furthermore, medical datasets lack the vast quantity of data characteristic of natural images. Transformers, with their numerous parameters, 作者: Gudgeon 時間: 2025-3-24 01:47
Komal Parmar,Jayvadan Patel possible to analyze complex bacterial populations and investigate relationships between individual strains. Methods such as core genome multilocus sequence typing (cgMLST) are used in routine clinical practice to characterize bacterial isolates, track the spread of infectious diseases, and monitor 作者: 輕快走過 時間: 2025-3-24 02:23 作者: aerial 時間: 2025-3-24 08:01 作者: HEAVY 時間: 2025-3-24 12:39 作者: hypnogram 時間: 2025-3-24 16:13 作者: 急性 時間: 2025-3-24 22:28 作者: FIN 時間: 2025-3-24 23:18
Global Health and Viral Diseases: Past, Present, and Future,he viruses can be beneficial to global health overall. Some of these common and dangerous viral diseases include influenza, HIV/AIDS, HPV, and measles, mumps, and rubella (MMR). Prior to modern medicine, thousands faced death at the hand of these diseases; however, today, we can develop intervention作者: 碌碌之人 時間: 2025-3-25 03:55
Drug Resistance in Antiviral Therapy,iral replication and protracted drug exposure result in selection of resistant strains. Consequences of drug resistance range from toxicity inherent in the use of second-line antiviral agents, severe disease, and even death (from progressive viral infection when no effective alternative treatment is作者: phytochemicals 時間: 2025-3-25 11:10 作者: STIT 時間: 2025-3-25 15:19 作者: 擦試不掉 時間: 2025-3-25 17:44 作者: Flustered 時間: 2025-3-25 22:43
Micro- and Nanoemulsions in Antiviral Treatment,clinical outcome. Microemulsions are soft nanocarriers bestowed with thermodynamic stability, easy formulation technique, high entrapment efficiency, and modifying release. Microemulsions have the ability to improve the solubility and stability, reducing dose-dependent toxicity of the drug and thus 作者: frenzy 時間: 2025-3-26 03:13
Novel Formulation Approaches for Treatment of Ebola Virus,rd of May 2021, professed the ongoing Ebola outbreak to be over. Ebola virus is acknowledged to be the causative agent of Ebola viral disease (EVD) or Ebola fever, which is of an hemorrhagic nature, a viral hemorrhagic disease found in humans in addition to some arboreal primates. The diagnosis is m作者: 吸引人的花招 時間: 2025-3-26 06:16 作者: dictator 時間: 2025-3-26 10:19
Polymers for Biosensing Applications in Viral Detection and Diagnosis, In order to reduce the transmission of the virus and to contain the illness epidemic, early detection and treatment are crucial. When subjected to extensive and quick testing, the present standard technologies reveal practical constraints and difficulties..Due to its numerous benefits, including hi作者: 紡織品 時間: 2025-3-26 14:12
Nanotechnology: A Stepping Stone Toward Viral Hepatitis Treatment and Prevention in Children and Ad and contaminated food, water, and objects. The implications of obtaining viral hepatitis differ depending on which type of virus is transmitted. Some individuals might experience no symptoms and not even realize they have the virus, and some might experience acute symptoms which can progress to chr作者: LEVY 時間: 2025-3-26 16:49 作者: MEEK 時間: 2025-3-27 00:07
COVID-19: Molecular Pathogenesis and Prospective Therapeutic Interventions,e for causing COVID-19 is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronaviruses (CoV) are named owing to the existence/appearance of the crown-like spike proteins on their surface. In the twenty-first century, they have emerged as severely devastating, transmissible, and pathog作者: Mangle 時間: 2025-3-27 02:14
Nano-Drug Delivery Systems for COVID-19 Drug Delivery,d the world. Many antivirals are under trial for the treatment of the infection. However, efficacy of drugs is often limited due to certain factors associated with the drug. Such problems can be overcome by using novel drug delivery systems employing nanotechnology. These delivery systems can be man作者: Gullible 時間: 2025-3-27 07:14
Exploring the Link Between Malaria and COVID-19,es. There is a remarkable difference between the industrialized nations and developing countries, particularly .-endemic African countries, in the incidence and mortality rate of COVID-19. Many factors enter into the equation when these observations are analyzed including cultural norms, testing ava作者: BAN 時間: 2025-3-27 13:30
The Use of Azithromycin and Lopinavir-Ritonavir in the Treatment of COVID-19,ith mild-to-severe symptoms. A common symptom of COVID-19-infected individuals is that of acute respiratory distress, such as fever, cough, and shortness of breath. COVID-19 causes pneumonia, acute respiratory syndrome, renal failure, and even, in severe cases, death. Clinical symptoms reported as p作者: Aviary 時間: 2025-3-27 15:49
Current Strategies to Combat COVID-19,igher infectivity and asymptomatic transmission is the major concern for this disease. The primary mode of transmission is by droplet and fomite. The symptoms are fever, dry cough, fatigue, shortness of breath, sore throat which advances to respiratory failure, septic shock, and multiple organ failu作者: Tincture 時間: 2025-3-27 18:59 作者: 淡紫色花 時間: 2025-3-27 23:42
Book 2023e quality-adjusted life year (QALY). Infectious diseases are one of the major to cause significant losses of DALY and QALY. Human infectious diseases are disorders that are triggered by the micro-organisms such as bacteria, fungi, viruses, or parasites. The majority of such diseases are contagious a作者: frenzy 時間: 2025-3-28 02:55 作者: ornithology 時間: 2025-3-28 09:00
ew nanoparticle delivery systemsThe disability-adjusted life year (DALY) is a generic measure of health effect that can be used in cost-effectiveness analysis as an alternative to the quality-adjusted life year (QALY). Infectious diseases are one of the major to cause significant losses of DALY and 作者: drusen 時間: 2025-3-28 12:03
Viral Infections: Current Treatment Options,Numerous bioinformatics sites continue updating virus genomes with their cell member structure protein to assist the drug developer in finding the safest treatment with good efficacy. The current chapter is focused on the comprehensive review of different types of viruses with an available treatment option.作者: 自作多情 時間: 2025-3-28 15:52
Polymers for Biosensing Applications in Viral Detection and Diagnosis,sors for viral detection, polymer-based biosensors can act as multisensory, mobile biosensors, and wearable biosensors. This book chapter provides various techniques of virus detection using polymers and also provides different strategies for virus biosensing and diagnosis.作者: FRAUD 時間: 2025-3-28 20:07
Recent Developments in the Treatment of Influenza,y during the first 2?days of symptom onset. Symptomatic management includes using immunomodulating drugs, such as hyperimmune IVIG and sirolimus. In 2018, the last drug to receive FDA approval for influenza infection, baloxavir marboxil, was approved. However, multiple investigational drugs are currently undergoing FDA trials.作者: Choreography 時間: 2025-3-29 00:28 作者: 藥物 時間: 2025-3-29 06:53
Global Health and Viral Diseases: Past, Present, and Future,a requirement for school admission. Supplementary immunization activities (SAIs) are also recommended to maintain and enforce immunization strategies. For viruses that result in sexually transmitted diseases (STIs), educational resources as well as screening opportunities are needed to aid in the ac作者: FLING 時間: 2025-3-29 10:09
Drug Resistance in Antiviral Therapy,utations is required for accurate interpretation of genotypic assays. Identification of viral resistance to drug therapy is possible by linking distinctive viral alterations (phenotypic resistance) to a number of antiviral drugs. To reduce antiviral resistance, there is the need to optimize drug adm作者: 完全 時間: 2025-3-29 13:51
Viral Diseases: Cellular Understanding of Diseases,rldwide are herpes simplex keratitis (HSK), Middle East respiratory syndrome coronavirus (MERS-CoV), and human immunodeficiency virus-1 (HIV-1). HSK is a double-stranded DNA virus (dsDNA) caused by the herpes simplex virus (HSV) infection of the cornea. HSK is one of the leading causes of blindness 作者: Mirage 時間: 2025-3-29 19:00
Mucosal Targeting Strategies for Antiviral Drug Delivery,s for site-specific mucosal antiviral drug delivery. Furthermore, mucosal delivery of antiviral drugs via the oral, nasal, and inhalation routes are assimilated and discussed in terms of current and future trends in this field.作者: GEST 時間: 2025-3-29 21:36 作者: Keratin 時間: 2025-3-30 02:36 作者: 狂怒 時間: 2025-3-30 07:14 作者: 擔(dān)心 時間: 2025-3-30 11:35
COVID-19: Molecular Pathogenesis and Prospective Therapeutic Interventions, the world health organization (WHO). The pathogen (SARS-CoV-2) targets the epithelial cells of the respiratory system, resulting in diffuse alveolar damage. Here, in this chapter, we have comprehensively reviewed the information regarding SARS-CoV-2 infections, its molecular basis of pathogenesis, 作者: 異常 時間: 2025-3-30 12:35
Exploring the Link Between Malaria and COVID-19,th limited per capita income..As the discussion in this article will show, the difference in the prevalence of COVID-19 among populations is correlated uneven propagation of the ACEI/D and the ACE2 (C1173T substitution) polymorphisms. The similarity of presentations between . and COVID-19 and the po作者: JOT 時間: 2025-3-30 19:31
The Use of Azithromycin and Lopinavir-Ritonavir in the Treatment of COVID-19,hrough both in vitro and clinical trials; the results of which have confirmed its potential application as part of COVID-19 treatment therapy. In vitro tests conducted on Vero cells indicated that a combination of lopinavir/ritonavir and azithromycin is highly effective in inhibiting viral replicati作者: 污穢 時間: 2025-3-31 00:32
Current Strategies to Combat COVID-19,he article. Currently used therapeutics for COVID-19 like remdesivir, chloroquine, and hydroxychloroquine, lopinavir/ritonavir, ribavirin, favipiravir, Arbidol, convalescent plasma therapy are discussed.作者: conscribe 時間: 2025-3-31 04:08
Phytomolecules and Novel Drug Delivery Approach for COVID-19, natural phytoconstituents are efficient home remedies for COVID-19 therapy for quick recovery and immune modulators as a preventive measure. In this chapter, we’ve discussed the value of natural substances in the treatment of COVID-19 as well as contemporary integrated pharmaceutical therapies that作者: Exposure 時間: 2025-3-31 07:20 作者: 歌劇等 時間: 2025-3-31 09:32 作者: 排他 時間: 2025-3-31 16:27
